Development of a drug testing platform for recessive dystrophic epidermolysis bullosasquamous cell carcinoma using induced pluripotent cancer cells

Project: Research

Project Details

StatusActive
Effective start/end date1/12/202030/11/2026

Funding

  • EB Research Partnership: £159,815.00